Sera Prognostics (SERA) Gains from Investment Securities (2020 - 2026)
Sera Prognostics (SERA) reported Gains from Investment Securities of $7.2 million for Q1 2026, up 8.92% on a YoY basis from $6.6 million in Q1 2025, and up 3906.22% quarter-over-quarter from -$188000.0 in Q4 2025.
Sera Prognostics (SERA) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Gains from Investment Securities for 7 years, with the latest figure at $7.2 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 8.92% year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 8.92% YoY), and the FY2025 full-year result was $6.5 million, up 6.73% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $7.2 million, up from -$188000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $7.2 million in Q1 2026, with the low at -$188000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $1.3 million across 5 years, with a median of $108000.0 in 2024.
- The largest YoY upside for Gains from Investment Securities was 6006.98% in 2025 against a maximum downside of 141.23% in 2025.
- Sera Prognostics' Gains from Investment Securities stood at -$164000.0 in 2022, then surged by 736.59% to $1.0 million in 2023, then sank by 56.32% to $456000.0 in 2024, then slumped by 141.23% to -$188000.0 in 2025, then jumped by 3906.22% to $7.2 million in 2026.
- The last three Gains from Investment Securities figures came in at $7.2 million (Q1 2026), -$188000.0 (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.16 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | -188,000.00 |
| Dec 31, 2025 | -188,000.00 |
| Sep 30, 2025 | 6.47 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 6.57 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 456,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 105,928.00 |
| Sep 30, 2024 | 105,928.00 |
| Jun 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 109,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |